Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer

Eva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova, Shane Foo, Emmanuel C. Patin, Harriet Whittock, Richard Buus, Syed Haider, Gareth Muirhead, Khin Thway, Kate Newbold, Robert S. Coffin, Richard G. Vile, Dae Kim, Martin McLaughlin, Alan A. Melcher, Kevin J. Harrington, Malin Pedersen

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences